about
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic SyndromeCirculating Markers of Liver Function and Cardiovascular Disease RiskCancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancerNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis.Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.Age and cigarette smoking are independently associated with the cutaneous vascular response to local warming.Daily energy expenditure, cardiorespiratory fitness and glycaemic control in people with type 1 diabetesEvaluation of a new high power, wide separation laser Doppler probe: potential measurement of deeper tissue blood flow.Mulberry-extract improves glucose tolerance and decreases insulin concentrations in normoglycaemic adults: Results of a randomised double-blind placebo-controlled study.Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring.Gaussian Process modelling of blood glucose response to free-living physical activity data in people with type 1 diabetes.A novel medium throughput quantitative competitive PCR technology to simultaneously measure mRNA levels from multiple genes.Triglyceride-rich lipoproteins: are links with atherosclerosis mediated by a procoagulant and proinflammatory phenotype?Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshopWeight loss surgery for non-morbidly obese populations with type 2 diabetes: is this an acceptable option for patients?Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study.Adipocyte metabolism and the metabolic syndrome.The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia.Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.Expression of AdipoR1 in vivo in skeletal muscle is independently associated with measures of truncal obesity in middle-aged caucasian men.Interaction between maternal and offspring diet to impair vascular function and oxidative balance in high fat fed male mice.Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.Differential priming of RNA templates during cDNA synthesis markedly affects both accuracy and reproducibility of quantitative competitive reverse-transcriptase PCR.ABC of obesity. Risk factors for diabetes and coronary heart disease.Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.Review: fluoxetine, orlistat, and sibutramine modestly reduce weight in type 2 diabetes.Mulberry extract to modULate Blood glucosE Responses in noRmoglYcaemic adults (MULBERRY): study protocol for a randomised controlled trial.Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre TrialRandomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction).Views of People With High and Low Levels of Health Literacy About a Digital Intervention to Promote Physical Activity for Diabetes: A Qualitative Study in Five Countries.The metabolic syndrome and type 2 diabetes.Intrauterine growth, the vascular system, and the metabolic syndrome.Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study.Triglycerides and disease.MNK1 and MNK2 mediate adverse effects of high-fat feeding in distinct waysAltered cellular redox status, sirtuin abundance and clock gene expression in a mouse model of developmentally primed NASH.Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.
P50
Q26765455-8AF1554E-45C2-475C-9BEE-B843F6BF8CEEQ28082614-45B1C133-CE83-4578-9262-3480B83ED155Q28222481-6452F3D0-FA3C-40E1-8B0F-C47867D2BCBEQ30235846-83B975F7-52EE-4A32-B567-AF8131351C80Q30248353-9EAF1FF1-D7CE-47F1-9EC1-E98A6E69E2FFQ30278545-F071DA52-1D47-4A21-B5A1-E705895777C9Q30881944-EA2A560B-3D46-4C3F-8318-AA8D8FDABE3CQ31161193-278A4CD0-E543-431E-92D9-F1471E949885Q33450026-986CF027-46EF-43FD-86CF-E35A5ED90F1CQ33469871-3033E6FB-FA4E-4160-8334-87AC8AED95A3Q33511008-2B10F738-8ABD-4555-A01D-51E36ED0F3D3Q33517299-07BCF87E-4250-4FE0-93DE-59A67F1AD1BDQ33584283-6EE116EF-6822-4CE6-980B-0B1823687920Q33700652-720E40EF-7F77-4E44-9EB8-A54486C3AEEAQ33791133-205F9DCD-EC94-41DA-A97E-2B094442E1B3Q33915304-55283E39-66E2-4F31-8FF8-0B8D41E5DA4BQ34224310-470D9B68-8B77-4424-B43F-E61754BF89BFQ34285949-5CAF02BA-EFBA-4D58-8DB4-09918CFE4351Q34304375-DB77DACA-4BD4-497A-A8E8-321A6EF8617FQ34329644-C76042BF-3B02-4192-97D0-899B3DC3FBC3Q34436953-15F1537B-081E-4BEA-BE75-7B1B8C4D22A1Q34507047-D3D464A8-958C-463B-920F-28302A4D742EQ34603226-94BCC7DB-63C8-4410-976E-D3D37A6AFDC0Q34756295-8D537E51-E782-4F8C-B71E-3ABE1FDF77B3Q35128793-FA4BC338-313E-4517-83A9-F400CB671E37Q35841191-DDDA7E59-3A1C-4870-BBB1-A4524E4304CEQ36012847-A669C5AA-80B1-44C2-8526-974DB84E6F7CQ36223518-0A4A4EBF-F55B-416B-9649-F243A5D1BDC3Q36225138-C25F9960-0A47-490B-A381-85FB7E66599FQ36260432-89482F49-8892-46E6-8E01-A892CCCA2AD2Q36272989-149FFF37-63CC-47B8-AAA3-2436A6F9E03CQ36278605-32311350-0270-40BA-9F50-9F36C8FB09D5Q36285184-33DDA6C6-F92E-41E1-B779-62A5930841A2Q36306272-39F8ED0F-71C2-4016-A018-4735153841E5Q36538004-18A0A740-04F7-4F31-BD13-72D3CE0D4E6AQ36683565-9930307F-4162-482B-94D5-9CD72499DADAQ36806537-F8FF4973-FC36-403F-97D4-2E0D748583ECQ36922394-70EEB3E0-2B4B-4880-9AD3-436B3F854E24Q36934810-FF210742-4D01-4558-AA8A-6E6902BDB418Q36966063-C9DF5B12-FF91-45FB-93CE-4BB0ED52B4F8
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Christopher D Byrne
@ast
Christopher D Byrne
@en
Christopher D Byrne
@es
Christopher D Byrne
@nl
Christopher D Byrne
@sl
type
label
Christopher D Byrne
@ast
Christopher D Byrne
@en
Christopher D Byrne
@es
Christopher D Byrne
@nl
Christopher D Byrne
@sl
prefLabel
Christopher D Byrne
@ast
Christopher D Byrne
@en
Christopher D Byrne
@es
Christopher D Byrne
@nl
Christopher D Byrne
@sl
P214
P106
P1153
55603698800
P21
P214
P31
P496
0000-0001-6322-7753
P5008
P734
P735
P7859
lccn-nb2005015237